| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | EVP, General Counsel | $3.67 M | -$6.28 M | -63.1% | Apr 30, 2024 |
| RGNX | REGENXBIO Inc. | Director | $226 K | May 31, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|